期刊文献+

Depression, Anxiety, and Quality of Life in Paroxysmal Kinesigenic Dyskinesia Patients 被引量:6

Depression, Anxiety, and Quality of Life in Paroxysmal Kinesigenic Dyskinesia Patients
原文传递
导出
摘要 Background:Paroxysmal kinesigenic dyskinesia (PKD) is a rare movement disorder characterized by recurrent dystonic or choreoathetoid attacks triggered by sudden voluntary movements.Under the condition of psychological burden,some patients' attacks may get worsened with longer duration and higher frequency.This study aimed to assess nonmotor symptoms and quality of life of patients with PKD in a large population.Methods:We performed a cross-sectional survey in 165 primary PKD patients from August 2008 to October 2016 in Rui Jin Hospital,using Symptom Check List-90-Revised (SCL-90-R),World Health Organization Quality of Life-100 (WHOQoL-100),Self-Rating Depression Scale,and Self-Rating Anxiety Scale.We evaluated the differences of SCL-90-R and WHOQOL-100 scores in patients and Chinese normative data (taken from literature) by using the unpaired Student's t-test.We applied multivariate linear regression to analyze the relationships between motor manifestations,mental health,and quality of life among PKD patients.Results:Compared with Chinese normative data taken from literature,patients with PKD exhibited significantly higher (worse) scores across all SCL-90-R subscales (somatization,obsessive-compulsive,interpersonal sensitivity,depression,anxiety,hostility,phobic anxiety,paranoid ideation,and psychoticism;P =0.000 for all) and significantly lower (worse) scores of five domains in WHOQoL-100 (physical domain,psychological domain,independence domain,social relationship domain,and general quality of life;P =0.000 for all).Nonremission of dyskinesia episodes (P =0.011) and higher depression score (P =0.000) were significantly associated with lower levels of quality of life.The rates of depression and anxiety in patients with PKD were 41.2% (68/165) and 26.7% (44/165),respectively.Conclusions:Depression,anxiety,and low levels of quality of life were prevalent in patients with PKD.Co-occurrence of depression and anxiety was common among these patients.Regular mental health interventions could set depression and anxiety as intervention targets.Considering that the motor episodes could be elicited by voluntary movements and sometimes also by emotional stress,and that symptoms may get worsened with longer duration and higher frequency when patients are stressed out,intervention or treatment of depression and anxiety might improve the motor symptoms and overall quality of life in PKD patients. Background:Paroxysmal kinesigenic dyskinesia (PKD) is a rare movement disorder characterized by recurrent dystonic or choreoathetoid attacks triggered by sudden voluntary movements.Under the condition of psychological burden,some patients' attacks may get worsened with longer duration and higher frequency.This study aimed to assess nonmotor symptoms and quality of life of patients with PKD in a large population.Methods:We performed a cross-sectional survey in 165 primary PKD patients from August 2008 to October 2016 in Rui Jin Hospital,using Symptom Check List-90-Revised (SCL-90-R),World Health Organization Quality of Life-100 (WHOQoL-100),Self-Rating Depression Scale,and Self-Rating Anxiety Scale.We evaluated the differences of SCL-90-R and WHOQOL-100 scores in patients and Chinese normative data (taken from literature) by using the unpaired Student's t-test.We applied multivariate linear regression to analyze the relationships between motor manifestations,mental health,and quality of life among PKD patients.Results:Compared with Chinese normative data taken from literature,patients with PKD exhibited significantly higher (worse) scores across all SCL-90-R subscales (somatization,obsessive-compulsive,interpersonal sensitivity,depression,anxiety,hostility,phobic anxiety,paranoid ideation,and psychoticism;P =0.000 for all) and significantly lower (worse) scores of five domains in WHOQoL-100 (physical domain,psychological domain,independence domain,social relationship domain,and general quality of life;P =0.000 for all).Nonremission of dyskinesia episodes (P =0.011) and higher depression score (P =0.000) were significantly associated with lower levels of quality of life.The rates of depression and anxiety in patients with PKD were 41.2% (68/165) and 26.7% (44/165),respectively.Conclusions:Depression,anxiety,and low levels of quality of life were prevalent in patients with PKD.Co-occurrence of depression and anxiety was common among these patients.Regular mental health interventions could set depression and anxiety as intervention targets.Considering that the motor episodes could be elicited by voluntary movements and sometimes also by emotional stress,and that symptoms may get worsened with longer duration and higher frequency when patients are stressed out,intervention or treatment of depression and anxiety might improve the motor symptoms and overall quality of life in PKD patients.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第17期2088-2094,共7页 中华医学杂志(英文版)
关键词 ANXIETY DEPRESSION DYSKINESIA Quality of Life Anxiety Depression Dyskinesia Quality of Life
  • 相关文献

参考文献1

二级参考文献28

  • 1Fisher RS,van Emde Boas W,Blume W,Elger C Genton P Lee P. Epileptic seizures and epilepsy:definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)[J].{H}EPILEPSIA,2005.470-472.
  • 2Wang WZ,Wu JZ,Wang DS,Dai XY Yang B Wang TP. The prevalence and treatment gap in epilepsy in China:an ILAE/IBE/WHO study[J].{H}NEUROLOGY,2003.1544-1545.
  • 3Van Ness PC. Therapy for the epilepsies[J].{H}Archives of Neurology,2002.732-735.
  • 4Lanska DJ. Corning and vagal nerve stimulation for seizures in the 1880s[J].{H}NEUROLOGY,2002.452-459.
  • 5Helmers SL,Duh MS,Guérin A,Sarda SP Samuelson TM Bunker MT. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy[J].{H}Epilepsy & Behavior,2011.370-375.
  • 6Cohen-Gadol AA,Britton JW,Wetjen NM,Marsh WR Meyer FB Raffel C. Neurostimulation therapy for epilepsy:current modalities and future directions[J].{H}Mayo Clinic Proceedings,2003.238-248.
  • 7Magdaleno-Madrigal VM,Martínez-Vargas D,Valdés-Cruz A,Almazán-Alvarado S Fernández-Mas R. Preemptive effect of nucleus of the solitary tract stimulation on amygdaloid kindling in freely moving cats[J].{H}EPILEPSIA,2010.438-444.
  • 8Henry TR. Therapeutic mechanisms of vagus nerve stimulation[J].{H}NEUROLOGY,2002.S3-S14.
  • 9Peuker ET,Filler TJ. The nerve supply of the human auricle[J].{H}Clinical Anatomy,2002.35-37.
  • 10He W,Rong PJ,Li L,Ben H Zhu B Litscher G. Auricular acupuncture may suppress epileptic seizures via activating the parasympathetic nervous system:a hypothesis based on innovative methods[J].{H}Evidence-based Complementary and Alternative Medicine,2012.615476.

共引文献22

同被引文献43

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部